The following is a summary of "Global burden of gallbladder and biliary diseases (1990–2021) with healthcare workforce ...

Biliary tract infections (BTI), often linked to structural abnormalities like bile duct stones, pose significant treatment challenges due to drug-resistant bacteria like Pseudomonas aeruginosa. Phage ...

The liver is one of the body’s most vital organs, working tirelessly behind the scenes to detoxify, regulate metabolism, ...

Background: The presence of infective microorganisms in the bilio-pancreatic tract is believed to be important in both the onset and outcome of acute biliary pancreatitis. In this study ...

The following is a summary of "Risk of post-ERCP pancreatitis due to placement of biliary self-expandable metal stents (SEMS) ...

Compass Therapeutics (NASDAQ:CMPX) stock gains as its oncology drug tovecimig hits main goal in a Phase 2/3 trial for biliary tract cancer. Read more here.

New research shows that platelet count-related ratios, when combined with SOFA scores, can accurately predict severity in biliary bloodstream infections caused by E. coli and K. pneumoniae.

PUDUCHERRY: The Department of Surgical Gastroenterology at JIPMER, in association with the Association of Minimal Access ...

The ongoing COMPANION-002 trial has been evaluating the candidate, tovecimig (formerly CTX-009), alongside paclitaxel in ...

The patient was diagnosed with nongerminal-center B cell diffuse large B-cell lymphoma (DLBCL) 1 year after being diagnosed with primary biliary cholangitis (PBC).

Compass Therapeutics (CMPX) announced statistically significant top-line data on the primary efficacy endpoint for COMPANION-002, the Company’s ...

The primary end point of overall response rate has been met in the COMPANION-002 trial of tovecimig and paclitaxel in ...